CDEK
← All organizations

Pliva

For profitContributed to NME

Also known as: PLIVA | Pliva Hrvatska d.o.o. | PLIVA HRVATSKA DOO | PLIVA LACHEMA | PLIVA PHARM IND

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2015

First marketed drug

Jun 1, 1981

Last known activity

Dec 1, 2015

Acquired by Barr Laboratories → Teva on Jan 1, 2006

Timeline

1920s

  1. Jan 1, 1921

    Pliva— Founded

1990s

  1. Apr 26, 1996

    triamterene— Marketing Organization

  2. Jan 1, 1999

    Lachema— Acquired

  3. Jan 1, 1999

    Mixis Genetics— Acquired

2000s

  1. Jan 1, 2001

    Dominion Pharma Ltd— Acquired

  2. Jul 31, 2001

    AWD.pharma GmbH & Co. KG— Acquired

  3. Jan 1, 2002

    Sidmak Laboratories— Acquired

  4. Jan 1, 2006

    Barr Laboratories— Acquired By

  5. Jan 6, 2009

    Teva— Now

Drugs by trial phase (3 distinct, 3 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 1 (0 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (55)

Subsidiaries (5 direct, 6 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Zagreb, HR Jan 1, 1921
Last known activity
Dec 1, 2015